JACC: CardioOncology - The Ticagrelor-Oncology (TICONC) Study: Implications of P2Y12 Inhibition for Metastasis and Cancer-Associated Thrombosis
Jun 16, 2020
2:35
Episode Description
Commentary by Dr. Paul Burridge
Proudly Supported by
Patrons of Health Podcast Library
Supporting Shows
